Ekwaru John Paul, Zwicker Jennifer D, Holick Michael F, Giovannucci Edward, Veugelers Paul J
School of Public Health, University of Alberta, Edmonton, Alberta, Canada.
School of Public Policy, University of Calgary, Calgary, Alberta, Canada.
PLoS One. 2014 Nov 5;9(11):e111265. doi: 10.1371/journal.pone.0111265. eCollection 2014.
Unlike vitamin D recommendations by the Institute of Medicine, the Clinical Practice Guidelines by the Endocrine Society acknowledge body weight differentials and recommend obese subjects be given two to three times more vitamin D to satisfy their body's vitamin D requirement. However, the Endocrine Society also acknowledges that there are no good studies that clearly justify this. In this study we examined the combined effect of vitamin D supplementation and body weight on serum 25-hydroxyvitamin (25(OH)D) and serum calcium in healthy volunteers. We analyzed 22,214 recordings of vitamin D supplement use and serum 25(OH)D from 17,614 healthy adult volunteers participating in a preventive health program. This program encourages the use of vitamin D supplementation and monitors its use and serum 25(OH)D and serum calcium levels. Participants reported vitamin D supplementation ranging from 0 to 55,000 IU per day and had serum 25(OH)D levels ranging from 10.1 to 394 nmol/L. The dose response relationship between vitamin D supplementation and serum 25(OH)D followed an exponential curve. On average, serum 25(OH)D increased by 12.0 nmol/L per 1,000 IU in the supplementation interval of 0 to 1,000 IU per day and by 1.1 nmol/L per 1,000 IU in the supplementation interval of 15,000 to 20,000 IU per day. BMI, relative to absolute body weight, was found to be the better determinant of 25(OH)D. Relative to normal weight subjects, obese and overweight participants had serum 25(OH)D that were on average 19.8 nmol/L and 8.0 nmol/L lower, respectively (P<0.001). We did not observe any increase in the risk for hypercalcemia with increasing vitamin D supplementation. We recommend vitamin D supplementation be 2 to 3 times higher for obese subjects and 1.5 times higher for overweight subjects relative to normal weight subjects. This observational study provides body weight specific recommendations to achieve 25(OH)D targets.
与美国医学研究所的维生素D建议不同,美国内分泌学会的临床实践指南承认体重差异,并建议肥胖受试者应摄入多两到三倍的维生素D,以满足其身体对维生素D的需求。然而,内分泌学会也承认,目前尚无充分的研究能明确证实这一点。在本研究中,我们检测了健康志愿者补充维生素D和体重对血清25-羟基维生素D(25(OH)D)及血清钙的综合影响。我们分析了参与预防性健康计划的17,614名健康成年志愿者的22,214条维生素D补充剂使用记录和血清25(OH)D数据。该计划鼓励使用维生素D补充剂,并监测其使用情况以及血清25(OH)D和血清钙水平。参与者报告的每日维生素D补充量为0至55,000国际单位,血清25(OH)D水平为10.1至394纳摩尔/升。维生素D补充剂与血清25(OH)D之间的剂量反应关系呈指数曲线。平均而言,在每日补充量为0至1,000国际单位的区间内,每增加1,000国际单位,血清25(OH)D增加12.0纳摩尔/升;在每日补充量为15,000至20,000国际单位的区间内,每增加1,000国际单位,血清25(OH)D增加1.1纳摩尔/升。相对于绝对体重,体重指数(BMI)被发现是25(OH)D更好的决定因素。相对于正常体重受试者,肥胖和超重参与者的血清25(OH)D平均分别低19.8纳摩尔/升和8.0纳摩尔/升(P<0.001)。随着维生素D补充量的增加,我们未观察到高钙血症风险有任何增加。我们建议,相对于正常体重受试者,肥胖受试者的维生素D补充量应高出2至3倍,超重受试者应高出1.5倍。这项观察性研究提供了针对不同体重的建议,以实现25(OH)D目标。